David Ingbar, MD

Trials

Studies that name David Ingbar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:37 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04725110 · Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome

  University of Minnesota · withdrawn · Covid19, SARS-CoV Infection, ARDS · study chair
• Ph2
  NCT04466098 · Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

  Masonic Cancer Center, University of Minnesota · completed · Acute Respiratory Distress Syndrome, ARDS (Moderate or Severe), COVID-19 Pneumonia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 06:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.